Medical device licence · 65056 · Class 2
ALPHA-HBDH (LACTIC DEHYDROGENASE)
No longer licensed: discontinued at renewal
Licence status Discontinued at renewal; first licensed July 6, 2004; ended November 3, 2008. It is in Health Canada’s archive of licences no longer in force.
- Licence number
- 65056
- Licence holder
- Randox Laboratories Ltd.Crumlin, AT, United Kingdom
- Risk class
- Class II (low to moderate risk)
- Licence type
- Test Kit
- First licensed
- July 6, 2004
- Ended
- November 3, 2008
- Devices covered
- 4
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- ALPHA-HBDH OPT (LACTIC DEHYDROGENASE) MANUAL UV METHOD
- ALPHA-HBDH OPT (LACTIC DEHYDROGENASE) UV METHOD FOR HITACHI 717/911/912
- ALPHA-HBDH OPT (LACTIC DEHYDROGENASE) UV METHOD FOR HITACHI 917/MODULAR P
- ALPHA-HBDH OPT (LACTIC DEHYDROGENASE) UV METHOD HITACHI 704/717/902/911/912
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.